ニコチンは,POMCニューロンの活性化により,食物の摂取量を減少させます
Yann S Mineur1, Alfonso Abizaid, Yan Rao
1Department of Psychiatry, Yale University School of Medicine, 34 Park Street, Third Floor Research, New Haven, CT 06508, USA.
まとめ
喫煙によるニコチンは,食物摂取を制御する特定の脳受容体を活性化することによって食欲を減少させます. この研究は,喫煙が体重にどのように影響するかを明らかにし,肥満と禁煙治療のターゲットを提供します.
科学分野:
- 神経生物学 神経生物学とは
- エンドクリノロジー エンドクリノロジー
- 薬理学 薬理学とは
背景:
- 喫煙は食欲の減少と体重管理と関連しています.
- 禁煙と肥満の治療法を開発するために,喫煙の食欲低下効果の神経生物学的な基礎を理解することは極めて重要です.
研究 の 目的:
- ニコチン誘発の食欲抑制の背後にある神経生物学的メカニズムを解明する.
- 食物摂取と体重に対するニコチンの影響に関与する特定の神経経路と受容体を特定する.
主な方法:
- 薬理学,分子遺伝学,電気生理学,およびマウスの飼育の研究の組み合わせを使用しました.
- ヒポタラム内ニコチンアセチルコリン受容体とメラノコルチン系の役割を研究した.
主要な成果:
- ヒポタラム α3β4 ニコチンアセチルコリン受容体の活性化は,プロオピオメラノコルチン (POMC) ニューロンを刺激する.
- POMCニューロンとメラノコルチン4受容体は,ニコチンの食欲抑制効果をマウスに与えるために不可欠です.
- ニコチンは,体内のメラノコルチン系を介して,食物の摂取量と体重を減らすことが示されました.
結論:
- ニコチンは,下垂体メラノコルチン系を調節することによって,食物の摂取量と体重を減少させます.
- ニコチンの食欲抑制効果の基礎となる主要な分子およびシナプスメカニズムを特定した.
- 禁煙と肥満管理のための新しい治療戦略のための基盤を提供します.
関連する概念動画
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Brainstem: Control Centers of Medulla
The medulla oblongata is a crucial part of the brainstem responsible for controlling various autonomic and involuntary functions. It contains several nuclei, including the olivary, cuneate, gracile, and solitary nuclei.
Olivary Nucleus
The olivary nucleus, or inferior olivary nucleus, is located within the ventrolateral part of the medulla oblongata. It is primarily involved in motor coordination and motor learning. The olivary nucleus receives input from the spinal cord, cerebellum, and motor...
Olivary Nucleus
The olivary nucleus, or inferior olivary nucleus, is located within the ventrolateral part of the medulla oblongata. It is primarily involved in motor coordination and motor learning. The olivary nucleus receives input from the spinal cord, cerebellum, and motor...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...

